XML 54 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Stock based compensation by job function [Line Items]        
Common Shares Available for Grant 24,600   24,600  
Compensation expense related to the company's stock-based compensation plans $ 40.3 $ 38.5 $ 102.0 $ 103.6
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Stock-based compensation expense related to stock options, SAR and ESPP grants 20.0 21.2 43.3 44.9
Lease And Well [Member]        
Stock based compensation by job function [Line Items]        
Compensation expense related to the company's stock-based compensation plans 10.3 9.7 32.9 30.4
Gathering And Processing Costs [Member]        
Stock based compensation by job function [Line Items]        
Compensation expense related to the company's stock-based compensation plans 0.4 0.4 1.0 0.9
Exploration Costs [Member]        
Stock based compensation by job function [Line Items]        
Compensation expense related to the company's stock-based compensation plans 6.0 6.7 19.3 20.2
General And Administrative [Member]        
Stock based compensation by job function [Line Items]        
Compensation expense related to the company's stock-based compensation plans $ 23.6 $ 21.7 $ 48.8 $ 52.1
Stock Options and SARs [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 21.87 $ 30.77
Expected Volatility (in hundredths)     38.04% 35.25%
Risk-Free Interest Rate (in hundredths)     0.83% 0.95%
Dividend Yield (in hundredths)     0.85% 0.60%
Expected Life (in years)     5 years 3 months 18 days 5 years 2 months 12 days
Stock Options and SARs Rollforward [Abstract]        
Outstanding at January 1 (in shares)     10,493 10,452
Granted (in shares)     2,029 2,122
Exercised (1) (in shares) [1]     (1,291) (1,351)
Forfeited (in shares)     (203) (226)
Outstanding at September 30 (2) (in shares) [2] 11,028 10,997 11,028 10,997
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract]        
Outstanding at January 1 (price per share)     $ 64.96 $ 54.43
Granted (price per share)     69.95 101.65
Exercised (1) (price per share) [1]     47.25 44.52
Forfeited (price per share)     80.12 62.95
Outstanding at September 30 (2) (price per share) [2] $ 67.67 $ 64.58 $ 67.67 $ 64.58
Stock Options and SARs Vested or Expected to Vest (in shares) [3] 10,653 10,568 10,653 10,568
Weighted average grant price for stock options/SARs vested or expected to vest (price per share) [3] $ 67.22 $ 63.92 $ 67.22 $ 63.92
Stock Options and SARs Exercisable at September 30 (in shares) [4] 6,121 5,573 6,121 5,573
Stock Options and SARs Exercisable at September 30 (price per share) [4] $ 57.34 $ 49.23 $ 57.34 $ 49.23
Intrinsic value of stock options/SARs exercised during the period [1]     $ 52.4 $ 78.0
Aggregate intrinsic value for outstanding stock options and SARs [2] $ 136.9 $ 384.9 $ 136.9 $ 384.9
Weighted average remaining contractual life for stock options/SARs outstanding (in years)     4 years 4 months 24 days 4 years 7 months 6 days
Aggregate intrinsic value of stock options/SARs vested or expected to vest [3] 135.7 376.6 $ 135.7 $ 376.6
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years)     4 years 3 months 18 days 4 years 6 months
Aggregate intrinsic value for exercisable units [4] 121.6 277.5 $ 121.6 $ 277.5
Weighted average remaining contractual life for exercisable options/SARs (in years)     3 years 1 month 6 days 3 years 3 months 18 days
Unrecognized compensation expense 112.2   $ 112.2  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     3 years  
ESPP [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 21.40 $ 21.27
Expected Volatility (in hundredths)     32.54% 25.12%
Risk-Free Interest Rate (in hundredths)     0.12% 0.08%
Dividend Yield (in hundredths)     0.72% 0.50%
Expected Life (in years)     6 months 6 months
Restricted Stock and Restricted Stock Units [Member]        
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract]        
Unrecognized compensation expense 194.5   $ 194.5  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 8 months 12 days  
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost $ 16.2 $ 13.9 $ 53.9 $ 53.4
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward]        
Outstanding at January 1 (in shares)     5,394 7,358
Granted (in shares)     1,036 1,024
Released (in shares) [5]     (1,250) (2,540)
Forfeited (in shares)     (152) (220)
Outstanding at September 30 (1) (in shares) [6] 5,028 5,622 5,028 5,622
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward]        
Outstanding at January 1 (price per share)     $ 64.39 $ 49.54
Granted (price per share)     77.90 99.00
Released (price per share) [5]     51.02 37.92
Forfeited (price per share)     74.83 59.36
Outstanding at September 30 (1) (price per share) [6] $ 70.18 $ 63.41 $ 70.18 $ 63.41
Intrinsic value of restricted stock and restricted stock units released during the year [5]     $ 102.5 $ 270.0
Aggregate intrinsic value of stock and units outstanding [6] $ 366.0 $ 556.7 $ 366.0 $ 556.7
Performance Units and Performance Stock [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 80.64 $ 119.27
Expected Volatility (in hundredths)     29.35% 32.18%
Risk-Free Interest Rate (in hundredths)     1.07% 1.18%
Term Of Zero- Coupon Risk- Free Interest Rate In Years Derived From Treasury Constant Maturities Yield Curve     3 years 3 months 4 days  
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract]        
Unrecognized compensation expense $ 6.4   $ 6.4  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     3 years 6 months  
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward]        
Outstanding at January 1 (in shares)     333 261
Granted (in shares)     72 72
Released (in shares)     0 0
Forfeited (in shares)     0 0
Outstanding at September 30 (1) (in shares) [7] 405 333 405 333
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward]        
Outstanding at January 1 (price per share)     $ 90.17 $ 82.18
Granted (price per share)     80.64 119.27
Released (price per share)     0.00 0.00
Forfeited (price per share)     0.00 0.00
Outstanding at September 30 (1) (price per share) [7] $ 88.48 $ 90.17 $ 88.48 $ 90.17
Aggregate intrinsic value of stock and units outstanding [7] $ 29.5 $ 33.0 $ 29.5 $ 33.0
Performance Units and Performance Stock [Abstract]        
Share-Based Compensation Arrangement By Performance Units and Performance Stock Compensation Cost $ 4.1 $ 3.4 $ 4.8 $ 5.3
[1] The total intrinsic value of stock options/SARs exercised for the nine months ended September 30, 2015 and 2014 was $52.4 million and $78.0 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at September 30, 2015 and 2014 was $136.9 million and $384.9 million, respectively. At September 30, 2015 and 2014, the weighted average remaining contractual life was 4.4 years and 4.6 years, respectively.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at September 30, 2015 and 2014 was $135.7 million and $376.6 million, respectively. At September 30, 2015 and 2014, the weighted average remaining contractual life was 4.3 years and 4.5 years, respectively.
[4] The total intrinsic value of stock options/SARs exercisable at September 30, 2015 and 2014 was $121.6 million and $277.5 million, respectively. At September 30, 2015 and 2014, the weighted average remaining contractual life was 3.1 years and 3.3 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released for the nine months ended September 30, 2015 and 2014 was $102.5 million and $270.0 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at September 30, 2015 and 2014 was $366.0 million and $556.7 million, respectively.
[7] The total intrinsic value of performance units and performance stock outstanding at September 30, 2015 and 2014 was $29.5 million and $33.0 million, respectively.